Cargando…
Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
OBJECTIVE: To assess whether bodyweight influences the efficacy and safety of dual antiplatelet therapy (DAT) in male patients with minor stroke or transient ischemic attack patients. MATERIALS AND METHODS: All 3,420 male participants coming from the Clopidogrel in High-Risk Patients with Acute Non-...
Autores principales: | Ma, Yan, Liu, Ying, Xu, Jie, Wang, Yilong, Wang, Yongjun, Du, Fenghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947844/ https://www.ncbi.nlm.nih.gov/pubmed/29773949 http://dx.doi.org/10.2147/TCRM.S156694 |
Ejemplares similares
-
Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients
por: Xu, Jie, et al.
Publicado: (2017) -
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
por: Wangqin, Runqi, et al.
Publicado: (2017) -
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022) -
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020) -
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)